Cargando…

Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

The ERS COVID-19 guidelines make recommendations for corticosteroids, anti-IL-6 monoclonal antibodies, baricitinib, anticoagulation and non-invasive respiratory support for hospitalised patients with COVID-19 https://bit.ly/3QgHH7U

Detalles Bibliográficos
Autores principales:	Roche, Nicolas, Crichton, Megan L., Goeminne, Pieter C., Cao, Bin, Humbert, Marc, Shteinberg, Michal, Antoniou, Katerina M., Ulrik, Charlotte Suppli, Parks, Helen, Wang, Chen, Vandendriessche, Thomas, Qu, Jieming, Stolz, Daiana, Brightling, Christopher, Welte, Tobias, Aliberti, Stefano, Simonds, Anita K., Tonia, Thomy, Chalmers, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363848/ https://www.ncbi.nlm.nih.gov/pubmed/35710264 http://dx.doi.org/10.1183/13993003.00803-2022

Ejemplares similares

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
por: Chalmers, James D., et al.
Publicado: (2021)

The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
por: Crichton, Megan L., et al.
Publicado: (2021)

Guidance production before evidence generation for critical issues: the example of COVID-19
por: Roche, Nicolas, et al.
Publicado: (2020)

European Respiratory Society clinical practice guidelines: methodological guidance
por: Nagavci, Blin, et al.
Publicado: (2022)

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
por: Artaraz, Amaia, et al.
Publicado: (2020)

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
por: Crichton, Megan L., et al.
Publicado: (2019)

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
por: Shteinberg, Michal, et al.
Publicado: (2021)

Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration
por: Shteinberg, Michal, et al.
Publicado: (2019)

International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel
por: Pletz, Mathias W., et al.
Publicado: (2020)

COVID-19: guidance on palliative care from a European Respiratory Society international task force
por: Janssen, Daisy J.A., et al.
Publicado: (2020)

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
por: Chalmers, James D., et al.
Publicado: (2017)

The EMBARC European Bronchiectasis Registry: protocol for an international observational study
por: Chalmers, James D., et al.
Publicado: (2016)

Is bronchiectasis really a disease?
por: Shteinberg, Michal, et al.
Publicado: (2020)

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
por: Ulrik, Charlotte Suppli
Publicado: (2012)

Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
por: Ulrik, Charlotte Suppli
Publicado: (2014)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland
por: Lewsey, James, et al.
Publicado: (2010)

European Respiratory Society statement on long COVID follow-up
por: Antoniou, Katerina M., et al.
Publicado: (2022)

Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic
por: Yaacoby-Bianu, Karin, et al.
Publicado: (2022)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Incidence and risk factors for exacerbations of asthma during pregnancy
por: Ali, Zarqa, et al.
Publicado: (2013)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Early life insults as determinants of chronic obstructive pulmonary disease in adult life
por: Savran, Osman, et al.
Publicado: (2018)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
por: Savran, Osman, et al.
Publicado: (2023)

If I tweet will you cite later? Follow-up on the effect of social media exposure on article downloads and citations
por: Tonia, Thomy, et al.
Publicado: (2020)

The wound-activated ERF15 transcription factor drives Marchantia polymorpha regeneration by activating an oxylipin biosynthesis feedback loop
por: Liang, Yuanke, et al.
Publicado: (2022)

A glimpse of the ERS International Congress 2022
por: Gompelmann, Daniela, et al.
Publicado: (2022)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Biomarkers in Pneumonia—Beyond Procalcitonin
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Specialist training in Europe: introduction to a special issue of the Journal of Thoracic Disease
por: Massard, Gilbert, et al.
Publicado: (2021)

Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better
por: Gregersen, Thorbjørn Lomholt, et al.
Publicado: (2013)

Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2021)

COVID-19 follow-up programmes across Europe: an ERS END-COVID CRC survey
por: Valenzuela, Claudia, et al.
Publicado: (2022)

Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021)

Towards a consensus on genotyping schemes for surveillance and outbreak investigations of Cryptosporidium, Berlin, June 2016
por: Chalmers, RM, et al.
Publicado: (2016)

Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis
por: Goeminne, Pieter C, et al.
Publicado: (2012)

ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group
por: Traversi, Letizia, et al.
Publicado: (2021)

Postpartum airway responsiveness and exacerbation of asthma during pregnancy – a pilot study
por: Ali, Zarqa, et al.
Publicado: (2017)

Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review
por: Ulrik, Charlotte Suppli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eodmmqqhegtpuohf42tptvabla